3-pyridinyl compounds
US6603011B1 · kind B1 · utility
13Cited by
8References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2000 |
| Grant date | Aug 5, 2003 |
| Priority date | — |
| Expiry date | Aug 21, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Patients susceptible to or suffering from central nervous system disorders are treated by administering effective amounts of aryl substituted aliphatic amine compounds, aryl substituted olefinic amine compounds or aryl substituted acetylenic amine compounds. A representative compound is (E)-N-methyl-5-(3-pyridinyl)-4-penten-2-amine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.